Cancer, more than a “COVID-19 co-morbidity”
Patients with cancer represent a particularly vulnerable population at risk of adverse outcomes related to COVID-19. Collectively, the initial studies, including patients with and without cancer, confirmed that patients with cancer had a higher risk of complications and death related to COVID-19. Su...
Main Authors: | Chinmay T. Jani, Robert T. Schooley, Rana R. Mckay, Scott M. Lippman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1107384/full |
Similar Items
-
Diabetes and covid-19: more than the sum of two morbidities
by: Bianca de Almeida Pititto, et al. -
Death analysis of COVID-19 patients admitted in dedicated COVID hospital in Mumbai
by: Pradnya N Pawar, et al.
Published: (2022-01-01) -
The relationship between the incidence of COVID-19 with the underlying diseases in hospitalized patients
by: Rasoul Raesi, et al.
Published: (2022-10-01) -
Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection
by: Weizheng Liang, et al.
Published: (2022-05-01) -
COVID-19 in Nigeria: Implications for Management of Related Co-morbidities, Prevalent Public Health Challenges, and Future Epidemic Preparedness
by: Toyin Togun, et al.
Published: (2020-06-01)